2% Chlorhexidine gluconate cloth
DrugDaily bathing
NCT Number: NCT00549393
The investigators propose to conduct a large clinical study to determine if daily bathing with chlorhexidine impregnated cloths will reduce the incidence of healthcare-associated infections in the Pediatric Intensive Care Unit (PICU).
Looking for future studies?
Notify Me2 month–25 year
All sexes
Interventional
Phase 2 / Phase 3
Children's National Medical Center, Washington D.C., District of Columbia, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily bathing
Time frame: participants were followed for the duration of ICU stay, median stay 3 days
incidence of bacteremia comparing those in treatment and control groups
Time frame: participants were followed for the duration of ICU stay, median stay 3 days
Comparing incidence of central line-associated bloodstream infections between treatment and control groups
Time frame: duration of ICU stay, median 3 days
per protocol analysis of incidence of bacteremia comparing those in treatment and control groups
Johns Hopkins University
Other
Impact of Daily Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01338116
Community-associated Infections, Cross Infection
Petah Tikvah, Israel
View Trial DetailsNCT04748432
Cross Infection, Disease Attributes
Konya, Turkey (Türkiye)
View Trial DetailsNCT02600195
Cross Infection, Disease Attributes
Hefei, Anhui, China
View Trial DetailsNCT02756351
Cross Infection, Disease Attributes
Stockholm, Stockholm County, Sweden
View Trial Details